Normal view MARC view ISBD view

The role of clinical nonfatal end points in cardiovascular phase II/III clinical trials.

O'Connor, C M

The role of clinical nonfatal end points in cardiovascular phase II/III clinical trials. [electronic resource] - American heart journal Apr 2000 - S143-54 p. digital

Publication Type: Journal Article

ISSN: 0002-8703

Standard No.: 10.1016/s0002-8703(00)90062-0 doi

Subjects--Topical Terms:
Cardiovascular Agents--adverse effects
Clinical Trials, Phase II as Topic--statistics & numerical data
Clinical Trials, Phase III as Topic--statistics & numerical data
Humans
Reproducibility of Results
Survival Analysis
Treatment Outcome

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)